NBC News
@NBCNews·11.9M subscribers·98K videos
FDA approves groundbreaking sickle cell anemia treatment
Posted
December 9, 2023
Views
30,101
Likes
524
Comments
106
Engagement
2.09%
December 9, 2023
30,101
524
106
2.09%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:35Now PlayingThe FDA has approved a groundbreaking cure for sickle cell anemia called Casgevy which uses the gene-editing tool CRISPR. NBC News’ Rehema Ellis has more details on the new hope for those suffering with the debilitating blood disorder.
» Subscribe to NBC News
NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.
Connect with NBC News Online!
Breaking News Alerts
Visit NBCNews.Com
Find NBC News on Facebook
Follow NBC News on Twitter
Get more of NBC News delivered to your inbox: nbcnews.com/newsletters
#SickleCellAnemia #GeneEditing #FDA
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
